270 related articles for article (PubMed ID: 26775128)
1. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.
Lee SH; Yoon SH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
Dig Liver Dis; 2016 Apr; 48(4):435-40. PubMed ID: 26775128
[TBL] [Abstract][Full Text] [Related]
2. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
[TBL] [Abstract][Full Text] [Related]
3. Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Pusceddu S; Vernieri C; Di Maio M; Marconcini R; Spada F; Massironi S; Ibrahim T; Brizzi MP; Campana D; Faggiano A; Giuffrida D; Rinzivillo M; Cingarlini S; Aroldi F; Antonuzzo L; Berardi R; Catena L; De Divitiis C; Ermacora P; Perfetti V; Fontana A; Razzore P; Carnaghi C; Davì MV; Cauchi C; Duro M; Ricci S; Fazio N; Cavalcoli F; Bongiovanni A; La Salvia A; Brighi N; Colao A; Puliafito I; Panzuto F; Ortolani S; Zaniboni A; Di Costanzo F; Torniai M; Bajetta E; Tafuto S; Garattini SK; Femia D; Prinzi N; Concas L; Lo Russo G; Milione M; Giacomelli L; Buzzoni R; Delle Fave G; Mazzaferro V; de Braud F
Gastroenterology; 2018 Aug; 155(2):479-489.e7. PubMed ID: 29655834
[TBL] [Abstract][Full Text] [Related]
4. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
[TBL] [Abstract][Full Text] [Related]
5. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
[TBL] [Abstract][Full Text] [Related]
6. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
7. Metformin and survival in pancreatic cancer: a retrospective cohort study.
Hwang AL; Haynes K; Hwang WT; Yang YX
Pancreas; 2013 Oct; 42(7):1054-9. PubMed ID: 24051965
[TBL] [Abstract][Full Text] [Related]
8. Metformin may improve the prognosis of patients with pancreatic cancer.
Zhang JW; Sun Q
Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of small cell lung cancer patients with diabetes treated with metformin.
Xu T; Liang G; Yang L; Zhang F
Clin Transl Oncol; 2015 Oct; 17(10):819-24. PubMed ID: 26063645
[TBL] [Abstract][Full Text] [Related]
10. Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation.
Chen TM; Lin CC; Huang PT; Wen CF
J Gastroenterol Hepatol; 2011 May; 26(5):858-65. PubMed ID: 21251068
[TBL] [Abstract][Full Text] [Related]
11. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
[TBL] [Abstract][Full Text] [Related]
12. Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum.
Wen-Xiu X; Xiao-Wei Z; Hai-Ying D; Ying-Hui T; Si-Si K; Xiao-Fang Z; Huang P
Medicine (Baltimore); 2018 Dec; 97(51):e13652. PubMed ID: 30572481
[TBL] [Abstract][Full Text] [Related]
13. Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer.
Kozak MM; Anderson EM; von Eyben R; Pai JS; Poultsides GA; Visser BC; Norton JA; Koong AC; Chang DT
Pancreas; 2016 Jan; 45(1):64-70. PubMed ID: 26474429
[TBL] [Abstract][Full Text] [Related]
14. The Influence of Metformin on Serum Carbohydrate Antigen 19-9 (CA 19-9) Levels in Type 2 Diabetes Mellitus Patients.
Ankit BS; Agrawal R; Gadhwal A; Chahar C; Agrawal RP
J Assoc Physicians India; 2018 Mar; 66(3):38-41. PubMed ID: 30341867
[TBL] [Abstract][Full Text] [Related]
15. Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes.
Spierings LE; Lagarde SM; van Oijen MG; Gisbertz SS; Wilmink JW; Hulshof MC; Meijer SL; Anderegg MC; van Berge Henegouwen MI; van Laarhoven HW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S766-71. PubMed ID: 26350367
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes.
Chen H; Yao W; Chu Q; Han R; Wang Y; Sun J; Wang D; Wang Y; Cao M; He Y
Cancer Lett; 2015 Dec; 369(1):97-102. PubMed ID: 26341687
[TBL] [Abstract][Full Text] [Related]
17. Association between Metformin Use and Survival in Nonmetastatic Rectal Cancer Treated with a Curative Resection: A Nationwide Population Study.
Ki YJ; Kim HJ; Kim MS; Park CM; Ko MJ; Seo YS; Moon SM; Choi JA
Cancer Res Treat; 2017 Jan; 49(1):29-36. PubMed ID: 27384155
[TBL] [Abstract][Full Text] [Related]
18. Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancer.
Jiamset I; Hanprasertpong J
J Gynecol Oncol; 2016 May; 27(3):e28. PubMed ID: 27029749
[TBL] [Abstract][Full Text] [Related]
19. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
20. Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes.
Tan BX; Yao WX; Ge J; Peng XC; Du XB; Zhang R; Yao B; Xie K; Li LH; Dong H; Gao F; Zhao F; Hou JM; Su JM; Liu JY
Cancer; 2011 Nov; 117(22):5103-11. PubMed ID: 21523768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]